To account for different internal climate variability states, the decade-long HAPPI time-slice experiments were uniquely set up with 90 ensemble members. The large ensembles allow for the study of extremes in specifically designed Paris Agreement scenarios. We used the 90-member ensemble of daily mean temperature simulations from the atmosphere-only general circulation model HadAM3P (29, 30). The ensemble members were initialized by applying perturbations to the potential temperature field of the atmosphere taken from consecutive 1-day difference fields in a long run of the model. HadAM3P has a horizontal latitude-longitude resolution of 1.25 × 1.875° (N96) (30, 60). Through the citizen science weather@home project (30, 60), we followed the HAPPI protocol (61) and used the 1.5° and 2°C time-slice experiments along with a new 3°C experiment. These experiments represent stabilized climates at 1.5°, 2°, and 3°C above preindustrial levels in any 10-year period in the future.

The HAPPI methodology (61) for determining the 2°C world calculated sea surface temperatures, sea ice concentrations, and the radiative forcing of well-mixed greenhouse gases by using a weighted sum of Representative Concentration Pathways (RPC) from the Coupled Model Intercomparison Project Phase 5 (CMIP5) (62). We used the same approach for the HAPPI 3°C experiment, but with different weighting. We took the weighted sum of the RCP4.5 and RCP8.5 scenarios in the form of 0.686 × RCP4.5 + 0.314 × RCP8.5. These weights were calculated such that the CMIP5 multi-model mean global mean temperature over 2091–2100 was ~3°C above the 1861–1880 level.

For estimation of future mortality in the cities of interest, we extracted the bias-corrected daily mean temperature time series (see below) over the land grid cells that were geographically closest to the individual cities.

Note: The content above has been extracted from a research article, so it may not display correctly.



Q&A
Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.



We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.